Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.


A novel, recombinant myxoma virus-rabbit haemorrhagic disease virus (RHDV) vaccine has been developed for the prevention of myxomatosis and rabbit haemorrhagic disease (RHD). A number of laboratory studies are described illustrating the safety and efficacy of the vaccine following subcutaneous administration in laboratory rabbits from four weeks of age… (More)
DOI: 10.1136/vr.100366


6 Figures and Tables

Slides referencing similar topics